Compare VYGR & ESP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VYGR | ESP |
|---|---|---|
| Founded | 2013 | 1928 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 203.6M | 165.6M |
| IPO Year | 2015 | 1995 |
| Metric | VYGR | ESP |
|---|---|---|
| Price | $3.48 | $60.04 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | $16.50 | ★ $64.00 |
| AVG Volume (30 Days) | ★ 568.1K | 35.2K |
| Earning Date | 05-08-2026 | 05-13-2026 |
| Dividend Yield | N/A | ★ 1.50% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 2.74 |
| Revenue | $10,135,000.00 | ★ $43,950,872.00 |
| Revenue This Year | $34.04 | $10.30 |
| Revenue Next Year | $7.92 | $10.00 |
| P/E Ratio | ★ N/A | $22.00 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.83 | $36.00 |
| 52 Week High | $5.55 | $74.77 |
| Indicator | VYGR | ESP |
|---|---|---|
| Relative Strength Index (RSI) | 43.51 | 48.44 |
| Support Level | $3.31 | $53.68 |
| Resistance Level | $4.29 | $61.58 |
| Average True Range (ATR) | 0.20 | 2.50 |
| MACD | -0.02 | 0.39 |
| Stochastic Oscillator | 30.77 | 76.09 |
Voyager Therapeutics Inc is a biotechnology company to leverage the power of human genetics to modify the course of and ultimately cure neurological diseases. Its pipeline includes programs for Alzheimer's disease, or AD; Friedreich's ataxia, or FA; Parkinson's disease, or PD; and multiple other diseases of the central nervous system, or CNS. Many of its programs are derived from its TRACER (Tropism Redirection of AAV by Cell-type-specific Expression of RNA) adeno-associated virus, or AAV, capsid discovery platform, which the company has used to generate novel capsids, or TRACER Capsids, and identify associated receptors to potentially enable high brain penetration with genetic medicines following intravenous, or IV, dosing. Its segment is developing and commercializing genetic medicine.
Espey Manufacturing & Electronics Corp is a power electronics design and OEM manufacturing company delivering products for military and severe environment applications. Its products include power supplies, power converters, filters, power transformers, magnetic components, power distribution equipment, UPS systems, and antennas. The applications of these products include AC and DC locomotives, shipboard power, shipboard radar, airborne power, ground-based radar, and ground mobile power. Espey services include design and development to specification, build to specifications provided by the customer, build to print, design services, design studies, environmental testing services, metal fabrication, painting services, and development of automatic testing equipment.